Form 483

BIOTECH EUROPE MEDITECH Inc. Ltd Form 483, 2022-04-14

FDA issued a Form 483 to BIOTECH EUROPE MEDITECH Inc. Ltd on 2022-04-14 with 4 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health4 observations

BIOTECH EUROPE MEDITECH Inc. Ltd · Roscommon, Ireland · Issued April 14, 2022

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 Apr 2022
21 CFR 820.100(b)

Documentation

Cited by Esteban Beltran

14 Apr 2022
21 CFR 820.22

Quality audits - auditor independence

Cited by Esteban Beltran

14 Apr 2022
21 CFR 820.70(a)

Production processes

Cited by Esteban Beltran

14 Apr 2022
21 CFR 820.75(a)

Lack of or inadequate process validation

Cited by Esteban Beltran

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(b)Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.70(a)Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere